Literature DB >> 155986

Left ventricular radius to wall thickness ratio.

W H Gaasch.   

Abstract

Left ventricular relative wall thickness, expressed as the ratio of end-diastolic radius to wall thickness (R/Th ratio), has a constant relation with left ventricular systolic pressure in children and adults with a normal heart, subjects with physiologic forms of cardiac hypertrophy (athletes) and patients with compensated chronic left ventricular volume overload (chronic aortic regurgitation). Greatly increased values for the radius/thickness ratio, suggesting inadequate hypertrophy, indicate a poor prognosis in patients with chronic aortic regurgitation and in those with congestive cardiomyopathy; decreased values for this ratio are found in patients with hypertrophic cardiomyopathy (inappropriate hypertrophy) and in patients with compensated aortic stenosis (appropriate hypertrophy). In patients with compensated aortic stenosis, echocardiographic measurement of the left ventricular end-diastolic radius/wall thickness ratio has been used to estimate left ventricular systolic pressure. Measurement of left ventricular relative wall thickness appears to provide diagnostic and prognostic data in patients with a broad variety of cardiac disorders.

Entities:  

Mesh:

Year:  1979        PMID: 155986     DOI: 10.1016/0002-9149(79)90152-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 2.  The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Amanda L Chancey; James A Stewart
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

3.  Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.

Authors:  E Foster; J F Plehn; S A Bernard; N J Battinelli; M Huntington-Coats; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

4.  Factors discriminating survivors and nonsurvivors in alcoholic heart disease.

Authors:  M Kino; Y Nakayama; M Hara; S Yamamoto; K Sawada; T Saitoh; M Suwa; Y Hirota; Y Kitaura; K Kawamura
Journal:  Heart Vessels Suppl       Date:  1985

5.  Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.

Authors:  Carolyn S P Lam; Jasmine Grewal; Barry A Borlaug; Steve R Ommen; Garvan C Kane; Robert B McCully; Patricia A Pellikka
Journal:  Hypertension       Date:  2010-03-09       Impact factor: 10.190

6.  Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.

Authors:  Izhak Kehat; Jennifer Davis; Malte Tiburcy; Federica Accornero; Marc K Saba-El-Leil; Marjorie Maillet; Allen J York; John N Lorenz; Wolfram H Zimmermann; Sylvain Meloche; Jeffery D Molkentin
Journal:  Circ Res       Date:  2010-12-02       Impact factor: 17.367

7.  Physiological left ventricular hypertrophy.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1984-08

8.  Effect of age related changes in chamber size, wall thickness, and heart rate on left ventricular function in normal children.

Authors:  M G St John Sutton; D L Marier; P J Oldershaw; R Sacchetti; D G Gibson
Journal:  Br Heart J       Date:  1982-10

9.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

10.  Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.

Authors:  G P Vyssoulis; E A Karpanou; C E Pitsavos; T K Kourtis; A A Paleologos; P K Toutouzas
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.